BMC Infectious Diseases (Sep 2012)

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

  • Podlekareva Daria N,
  • Reekie Joanne,
  • Mocroft Amanda,
  • Losso Marcelo,
  • Rakhmanova Aza G,
  • Bakowska Elzbieta,
  • Karpov Igor A,
  • Lazarus Jeffrey V,
  • Gatell Jose,
  • Lundgren Jens D,
  • Kirk Ole

DOI
https://doi.org/10.1186/1471-2334-12-229
Journal volume & issue
Vol. 12, no. 1
p. 229

Abstract

Read online

Abstract Background State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV patients based on four key indicators. Methods Four indicators of health care were assessed: Compliance with current guidelines on initiation of: 1) combination antiretroviral therapy (cART); 2) chemoprophylaxis; 3) frequency of laboratory monitoring; and 4) virological response to cART (proportion of patients with HIV-RNA 90% of time on cART). Results 7097 EuroSIDA patients were included from Northern (n = 923), Southern (n = 1059), West Central (n = 1290) East Central (n = 1366), Eastern (n = 1964) Europe, and Argentina (n = 495). Patients in Eastern Europe with a CD4 3 were less likely to initiate cART and Pneumocystis jiroveci-chemoprophylaxis compared to patients from all other regions, and less frequently had a laboratory assessment of their disease status. The proportion of patients with virological response was highest in Northern, 89% vs. 84%, 78%, 78%, 61%, 55% in West Central, Southern, East Central Europe, Argentina and Eastern Europe, respectively (p Conclusions This assessment of HIV health care utilization revealed pronounced regional differences in adherence to guidelines and can help to identify gaps and direct target interventions. It may serve as a tool for the assessment and benchmarking of the clinical management of HIV patients in any setting worldwide.

Keywords